nodes	percent_of_prediction	percent_of_DWPC	metapath
Dinoprost Tromethamine—SLCO3A1—Methotrexate—hematologic cancer	0.069	0.157	CbGbCtD
Dinoprost Tromethamine—SLC22A2—Daunorubicin—hematologic cancer	0.0609	0.139	CbGbCtD
Dinoprost Tromethamine—SLC22A2—Cytarabine—hematologic cancer	0.0537	0.123	CbGbCtD
Dinoprost Tromethamine—SLC22A2—Cladribine—hematologic cancer	0.0508	0.116	CbGbCtD
Dinoprost Tromethamine—SLC22A2—Imatinib—hematologic cancer	0.0467	0.107	CbGbCtD
Dinoprost Tromethamine—SLC22A8—Mercaptopurine—hematologic cancer	0.0405	0.0924	CbGbCtD
Dinoprost Tromethamine—SLC22A2—Vinblastine—hematologic cancer	0.0259	0.0592	CbGbCtD
Dinoprost Tromethamine—PTGFR—ovarian follicle—hematologic cancer	0.0243	0.275	CbGeAlD
Dinoprost Tromethamine—SLC22A2—Cisplatin—hematologic cancer	0.0238	0.0542	CbGbCtD
Dinoprost Tromethamine—SLC22A11—Methotrexate—hematologic cancer	0.0227	0.0519	CbGbCtD
Dinoprost Tromethamine—SLC22A7—Methotrexate—hematologic cancer	0.0217	0.0495	CbGbCtD
Dinoprost Tromethamine—SLC22A8—Methotrexate—hematologic cancer	0.0132	0.0302	CbGbCtD
Dinoprost Tromethamine—SLC22A6—Methotrexate—hematologic cancer	0.00922	0.021	CbGbCtD
Dinoprost Tromethamine—TBXA2R—hematopoietic system—hematologic cancer	0.00476	0.054	CbGeAlD
Dinoprost Tromethamine—HPGDS—hematopoietic system—hematologic cancer	0.00317	0.0359	CbGeAlD
Dinoprost Tromethamine—TBXA2R—blood—hematologic cancer	0.00315	0.0358	CbGeAlD
Dinoprost Tromethamine—TBXA2R—lung—hematologic cancer	0.00276	0.0314	CbGeAlD
Dinoprost Tromethamine—TBXA2R—testis—hematologic cancer	0.00261	0.0296	CbGeAlD
Dinoprost Tromethamine—PTGIR—hematopoietic system—hematologic cancer	0.00258	0.0293	CbGeAlD
Dinoprost Tromethamine—HPGDS—gonad—hematologic cancer	0.00241	0.0273	CbGeAlD
Dinoprost Tromethamine—PTGER3—lung—hematologic cancer	0.00213	0.0242	CbGeAlD
Dinoprost Tromethamine—HPGDS—blood—hematologic cancer	0.0021	0.0238	CbGeAlD
Dinoprost Tromethamine—HPGDS—bone marrow—hematologic cancer	0.00203	0.023	CbGeAlD
Dinoprost Tromethamine—PTGER3—testis—hematologic cancer	0.00201	0.0228	CbGeAlD
Dinoprost Tromethamine—PTGIR—gonad—hematologic cancer	0.00196	0.0223	CbGeAlD
Dinoprost Tromethamine—TBXA2R—lymph node—hematologic cancer	0.00189	0.0215	CbGeAlD
Dinoprost Tromethamine—HPGDS—lung—hematologic cancer	0.00184	0.0209	CbGeAlD
Dinoprost Tromethamine—HPGDS—testis—hematologic cancer	0.00173	0.0197	CbGeAlD
Dinoprost Tromethamine—SLCO3A1—gonad—hematologic cancer	0.00173	0.0197	CbGeAlD
Dinoprost Tromethamine—PTGIR—blood—hematologic cancer	0.00171	0.0194	CbGeAlD
Dinoprost Tromethamine—PTGFR—lung—hematologic cancer	0.0017	0.0193	CbGeAlD
Dinoprost Tromethamine—PTGFR—testis—hematologic cancer	0.0016	0.0182	CbGeAlD
Dinoprost Tromethamine—SLCO3A1—blood—hematologic cancer	0.00151	0.0171	CbGeAlD
Dinoprost Tromethamine—PTGIR—lung—hematologic cancer	0.0015	0.017	CbGeAlD
Dinoprost Tromethamine—PTGER3—lymph node—hematologic cancer	0.00146	0.0165	CbGeAlD
Dinoprost Tromethamine—SLC22A8—hematopoietic system—hematologic cancer	0.00142	0.0161	CbGeAlD
Dinoprost Tromethamine—PTGIR—testis—hematologic cancer	0.00141	0.0161	CbGeAlD
Dinoprost Tromethamine—SLC22A7—testis—hematologic cancer	0.00135	0.0153	CbGeAlD
Dinoprost Tromethamine—SLCO3A1—lung—hematologic cancer	0.00132	0.015	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—lung—hematologic cancer	0.00131	0.0149	CbGeAlD
Dinoprost Tromethamine—Dinoprostone—PTGER4—hematologic cancer	0.00128	0.432	CrCbGaD
Dinoprost Tromethamine—HPGDS—lymph node—hematologic cancer	0.00126	0.0143	CbGeAlD
Dinoprost Tromethamine—SLCO3A1—testis—hematologic cancer	0.00125	0.0142	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—testis—hematologic cancer	0.00124	0.014	CbGeAlD
Dinoprost Tromethamine—Latanoprost—SLC22A1—hematologic cancer	0.00123	0.415	CrCbGaD
Dinoprost Tromethamine—PTGFR—lymph node—hematologic cancer	0.00116	0.0132	CbGeAlD
Dinoprost Tromethamine—PTGIR—lymph node—hematologic cancer	0.00103	0.0116	CbGeAlD
Dinoprost Tromethamine—SLC22A8—blood—hematologic cancer	0.00094	0.0107	CbGeAlD
Dinoprost Tromethamine—SLCO3A1—lymph node—hematologic cancer	0.000905	0.0103	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—lymph node—hematologic cancer	0.000896	0.0102	CbGeAlD
Dinoprost Tromethamine—Dinoprostone—SLC22A1—hematologic cancer	0.000455	0.153	CrCbGaD
Dinoprost Tromethamine—Drowsiness—Doxorubicin—hematologic cancer	5.96e-05	0.000216	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Prednisolone—hematologic cancer	5.96e-05	0.000216	CcSEcCtD
Dinoprost Tromethamine—Headache—Carmustine—hematologic cancer	5.94e-05	0.000215	CcSEcCtD
Dinoprost Tromethamine—Shock—Dexamethasone—hematologic cancer	5.94e-05	0.000215	CcSEcCtD
Dinoprost Tromethamine—Shock—Betamethasone—hematologic cancer	5.94e-05	0.000215	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Triamcinolone—hematologic cancer	5.93e-05	0.000215	CcSEcCtD
Dinoprost Tromethamine—Rash—Alitretinoin—hematologic cancer	5.92e-05	0.000214	CcSEcCtD
Dinoprost Tromethamine—Agitation—Prednisone—hematologic cancer	5.92e-05	0.000214	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Alitretinoin—hematologic cancer	5.92e-05	0.000214	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Ifosfamide—hematologic cancer	5.9e-05	0.000214	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Cisplatin—hematologic cancer	5.9e-05	0.000213	CcSEcCtD
Dinoprost Tromethamine—Tachycardia—Dexamethasone—hematologic cancer	5.89e-05	0.000213	CcSEcCtD
Dinoprost Tromethamine—Tachycardia—Betamethasone—hematologic cancer	5.89e-05	0.000213	CcSEcCtD
Dinoprost Tromethamine—Bradycardia—Epirubicin—hematologic cancer	5.89e-05	0.000213	CcSEcCtD
Dinoprost Tromethamine—Headache—Alitretinoin—hematologic cancer	5.88e-05	0.000213	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Gemcitabine—hematologic cancer	5.87e-05	0.000213	CcSEcCtD
Dinoprost Tromethamine—Nausea—Thalidomide—hematologic cancer	5.86e-05	0.000212	CcSEcCtD
Dinoprost Tromethamine—Rash—Ifosfamide—hematologic cancer	5.85e-05	0.000212	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Ifosfamide—hematologic cancer	5.85e-05	0.000212	CcSEcCtD
Dinoprost Tromethamine—Hyperhidrosis—Betamethasone—hematologic cancer	5.83e-05	0.000211	CcSEcCtD
Dinoprost Tromethamine—Hyperhidrosis—Dexamethasone—hematologic cancer	5.83e-05	0.000211	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Irinotecan—hematologic cancer	5.83e-05	0.000211	CcSEcCtD
Dinoprost Tromethamine—Malaise—Prednisone—hematologic cancer	5.81e-05	0.00021	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Etoposide—hematologic cancer	5.8e-05	0.00021	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Etoposide—hematologic cancer	5.8e-05	0.00021	CcSEcCtD
Dinoprost Tromethamine—Urinary tract infection—Doxorubicin—hematologic cancer	5.79e-05	0.00021	CcSEcCtD
Dinoprost Tromethamine—Syncope—Prednisone—hematologic cancer	5.77e-05	0.000209	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Vincristine—hematologic cancer	5.75e-05	0.000208	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Cisplatin—hematologic cancer	5.74e-05	0.000208	CcSEcCtD
Dinoprost Tromethamine—Sweating—Doxorubicin—hematologic cancer	5.72e-05	0.000207	CcSEcCtD
Dinoprost Tromethamine—Rash—Vincristine—hematologic cancer	5.71e-05	0.000207	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Vincristine—hematologic cancer	5.7e-05	0.000206	CcSEcCtD
Dinoprost Tromethamine—Pain—Triamcinolone—hematologic cancer	5.69e-05	0.000206	CcSEcCtD
Dinoprost Tromethamine—Haematuria—Doxorubicin—hematologic cancer	5.68e-05	0.000206	CcSEcCtD
Dinoprost Tromethamine—Headache—Vincristine—hematologic cancer	5.67e-05	0.000205	CcSEcCtD
Dinoprost Tromethamine—Loss of consciousness—Prednisone—hematologic cancer	5.66e-05	0.000205	CcSEcCtD
Dinoprost Tromethamine—Hypotension—Betamethasone—hematologic cancer	5.64e-05	0.000204	CcSEcCtD
Dinoprost Tromethamine—Hypotension—Dexamethasone—hematologic cancer	5.64e-05	0.000204	CcSEcCtD
Dinoprost Tromethamine—Nausea—Carmustine—hematologic cancer	5.63e-05	0.000204	CcSEcCtD
Dinoprost Tromethamine—Epistaxis—Doxorubicin—hematologic cancer	5.62e-05	0.000204	CcSEcCtD
Dinoprost Tromethamine—Angiopathy—Methotrexate—hematologic cancer	5.61e-05	0.000203	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Mitoxantrone—hematologic cancer	5.6e-05	0.000203	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Irinotecan—hematologic cancer	5.6e-05	0.000203	CcSEcCtD
Dinoprost Tromethamine—Immune system disorder—Methotrexate—hematologic cancer	5.58e-05	0.000202	CcSEcCtD
Dinoprost Tromethamine—Nausea—Alitretinoin—hematologic cancer	5.58e-05	0.000202	CcSEcCtD
Dinoprost Tromethamine—Convulsion—Prednisone—hematologic cancer	5.58e-05	0.000202	CcSEcCtD
Dinoprost Tromethamine—Hypertension—Prednisone—hematologic cancer	5.56e-05	0.000201	CcSEcCtD
Dinoprost Tromethamine—Rash—Irinotecan—hematologic cancer	5.56e-05	0.000201	CcSEcCtD
Dinoprost Tromethamine—Rash—Mitoxantrone—hematologic cancer	5.56e-05	0.000201	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Irinotecan—hematologic cancer	5.55e-05	0.000201	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Mitoxantrone—hematologic cancer	5.55e-05	0.000201	CcSEcCtD
Dinoprost Tromethamine—Chills—Methotrexate—hematologic cancer	5.55e-05	0.000201	CcSEcCtD
Dinoprost Tromethamine—Headache—Irinotecan—hematologic cancer	5.52e-05	0.0002	CcSEcCtD
Dinoprost Tromethamine—Headache—Mitoxantrone—hematologic cancer	5.52e-05	0.0002	CcSEcCtD
Dinoprost Tromethamine—Nausea—Ifosfamide—hematologic cancer	5.51e-05	0.0002	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Triamcinolone—hematologic cancer	5.48e-05	0.000198	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Cisplatin—hematologic cancer	5.48e-05	0.000198	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Gemcitabine—hematologic cancer	5.46e-05	0.000198	CcSEcCtD
Dinoprost Tromethamine—Bradycardia—Doxorubicin—hematologic cancer	5.45e-05	0.000197	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Dexamethasone—hematologic cancer	5.42e-05	0.000196	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Betamethasone—hematologic cancer	5.42e-05	0.000196	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Prednisone—hematologic cancer	5.42e-05	0.000196	CcSEcCtD
Dinoprost Tromethamine—Rash—Gemcitabine—hematologic cancer	5.41e-05	0.000196	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Gemcitabine—hematologic cancer	5.41e-05	0.000196	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Etoposide—hematologic cancer	5.4e-05	0.000196	CcSEcCtD
Dinoprost Tromethamine—Headache—Gemcitabine—hematologic cancer	5.38e-05	0.000195	CcSEcCtD
Dinoprost Tromethamine—Nausea—Vincristine—hematologic cancer	5.38e-05	0.000195	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Prednisolone—hematologic cancer	5.33e-05	0.000193	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Etoposide—hematologic cancer	5.26e-05	0.00019	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Triamcinolone—hematologic cancer	5.26e-05	0.00019	CcSEcCtD
Dinoprost Tromethamine—Angiopathy—Epirubicin—hematologic cancer	5.25e-05	0.00019	CcSEcCtD
Dinoprost Tromethamine—Nausea—Mitoxantrone—hematologic cancer	5.24e-05	0.00019	CcSEcCtD
Dinoprost Tromethamine—Nausea—Irinotecan—hematologic cancer	5.24e-05	0.00019	CcSEcCtD
Dinoprost Tromethamine—Immune system disorder—Epirubicin—hematologic cancer	5.22e-05	0.000189	CcSEcCtD
Dinoprost Tromethamine—Infection—Prednisone—hematologic cancer	5.22e-05	0.000189	CcSEcCtD
Dinoprost Tromethamine—Back pain—Methotrexate—hematologic cancer	5.2e-05	0.000188	CcSEcCtD
Dinoprost Tromethamine—Chills—Epirubicin—hematologic cancer	5.19e-05	0.000188	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Etoposide—hematologic cancer	5.19e-05	0.000188	CcSEcCtD
Dinoprost Tromethamine—Shock—Prednisone—hematologic cancer	5.17e-05	0.000187	CcSEcCtD
Dinoprost Tromethamine—Pain—Betamethasone—hematologic cancer	5.16e-05	0.000187	CcSEcCtD
Dinoprost Tromethamine—Pain—Dexamethasone—hematologic cancer	5.16e-05	0.000187	CcSEcCtD
Dinoprost Tromethamine—Tachycardia—Prednisone—hematologic cancer	5.13e-05	0.000186	CcSEcCtD
Dinoprost Tromethamine—Nausea—Gemcitabine—hematologic cancer	5.1e-05	0.000185	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Cisplatin—hematologic cancer	5.09e-05	0.000184	CcSEcCtD
Dinoprost Tromethamine—Hyperhidrosis—Prednisone—hematologic cancer	5.08e-05	0.000184	CcSEcCtD
Dinoprost Tromethamine—Rash—Cisplatin—hematologic cancer	5.05e-05	0.000183	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Cisplatin—hematologic cancer	5.04e-05	0.000183	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Etoposide—hematologic cancer	5.02e-05	0.000182	CcSEcCtD
Dinoprost Tromethamine—Ill-defined disorder—Methotrexate—hematologic cancer	4.99e-05	0.000181	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Betamethasone—hematologic cancer	4.97e-05	0.00018	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Dexamethasone—hematologic cancer	4.97e-05	0.00018	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Dexamethasone—hematologic cancer	4.93e-05	0.000179	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Betamethasone—hematologic cancer	4.93e-05	0.000179	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Triamcinolone—hematologic cancer	4.9e-05	0.000177	CcSEcCtD
Dinoprost Tromethamine—Back pain—Epirubicin—hematologic cancer	4.87e-05	0.000176	CcSEcCtD
Dinoprost Tromethamine—Angiopathy—Doxorubicin—hematologic cancer	4.86e-05	0.000176	CcSEcCtD
Dinoprost Tromethamine—Malaise—Methotrexate—hematologic cancer	4.85e-05	0.000176	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Etoposide—hematologic cancer	4.85e-05	0.000176	CcSEcCtD
Dinoprost Tromethamine—Muscle spasms—Epirubicin—hematologic cancer	4.84e-05	0.000175	CcSEcCtD
Dinoprost Tromethamine—Immune system disorder—Doxorubicin—hematologic cancer	4.83e-05	0.000175	CcSEcCtD
Dinoprost Tromethamine—Chills—Doxorubicin—hematologic cancer	4.8e-05	0.000174	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Prednisolone—hematologic cancer	4.78e-05	0.000173	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Triamcinolone—hematologic cancer	4.77e-05	0.000173	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Betamethasone—hematologic cancer	4.77e-05	0.000173	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Dexamethasone—hematologic cancer	4.77e-05	0.000173	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Dexamethasone—hematologic cancer	4.77e-05	0.000173	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Betamethasone—hematologic cancer	4.77e-05	0.000173	CcSEcCtD
Dinoprost Tromethamine—Nausea—Cisplatin—hematologic cancer	4.75e-05	0.000172	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Prednisone—hematologic cancer	4.72e-05	0.000171	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Triamcinolone—hematologic cancer	4.7e-05	0.00017	CcSEcCtD
Dinoprost Tromethamine—Cough—Methotrexate—hematologic cancer	4.7e-05	0.00017	CcSEcCtD
Dinoprost Tromethamine—Ill-defined disorder—Epirubicin—hematologic cancer	4.67e-05	0.000169	CcSEcCtD
Dinoprost Tromethamine—Convulsion—Methotrexate—hematologic cancer	4.66e-05	0.000169	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Etoposide—hematologic cancer	4.66e-05	0.000169	CcSEcCtD
Dinoprost Tromethamine—Agitation—Epirubicin—hematologic cancer	4.63e-05	0.000168	CcSEcCtD
Dinoprost Tromethamine—Rash—Etoposide—hematologic cancer	4.62e-05	0.000167	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Etoposide—hematologic cancer	4.62e-05	0.000167	CcSEcCtD
Dinoprost Tromethamine—Headache—Etoposide—hematologic cancer	4.59e-05	0.000166	CcSEcCtD
Dinoprost Tromethamine—Chest pain—Methotrexate—hematologic cancer	4.58e-05	0.000166	CcSEcCtD
Dinoprost Tromethamine—Rash—Prednisolone—hematologic cancer	4.56e-05	0.000165	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Prednisolone—hematologic cancer	4.55e-05	0.000165	CcSEcCtD
Dinoprost Tromethamine—Malaise—Epirubicin—hematologic cancer	4.54e-05	0.000164	CcSEcCtD
Dinoprost Tromethamine—Headache—Prednisolone—hematologic cancer	4.53e-05	0.000164	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Methotrexate—hematologic cancer	4.53e-05	0.000164	CcSEcCtD
Dinoprost Tromethamine—Syncope—Epirubicin—hematologic cancer	4.52e-05	0.000163	CcSEcCtD
Dinoprost Tromethamine—Back pain—Doxorubicin—hematologic cancer	4.51e-05	0.000163	CcSEcCtD
Dinoprost Tromethamine—Muscle spasms—Doxorubicin—hematologic cancer	4.48e-05	0.000162	CcSEcCtD
Dinoprost Tromethamine—Loss of consciousness—Epirubicin—hematologic cancer	4.43e-05	0.00016	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Triamcinolone—hematologic cancer	4.4e-05	0.000159	CcSEcCtD
Dinoprost Tromethamine—Cough—Epirubicin—hematologic cancer	4.39e-05	0.000159	CcSEcCtD
Dinoprost Tromethamine—Convulsion—Epirubicin—hematologic cancer	4.36e-05	0.000158	CcSEcCtD
Dinoprost Tromethamine—Infection—Methotrexate—hematologic cancer	4.36e-05	0.000158	CcSEcCtD
Dinoprost Tromethamine—Nausea—Etoposide—hematologic cancer	4.35e-05	0.000158	CcSEcCtD
Dinoprost Tromethamine—Hypertension—Epirubicin—hematologic cancer	4.35e-05	0.000157	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Prednisone—hematologic cancer	4.33e-05	0.000157	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Dexamethasone—hematologic cancer	4.33e-05	0.000157	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Betamethasone—hematologic cancer	4.33e-05	0.000157	CcSEcCtD
Dinoprost Tromethamine—Ill-defined disorder—Doxorubicin—hematologic cancer	4.32e-05	0.000157	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Prednisone—hematologic cancer	4.3e-05	0.000156	CcSEcCtD
Dinoprost Tromethamine—Nausea—Prednisolone—hematologic cancer	4.29e-05	0.000156	CcSEcCtD
Dinoprost Tromethamine—Chest pain—Epirubicin—hematologic cancer	4.29e-05	0.000155	CcSEcCtD
Dinoprost Tromethamine—Agitation—Doxorubicin—hematologic cancer	4.28e-05	0.000155	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Dexamethasone—hematologic cancer	4.27e-05	0.000155	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Betamethasone—hematologic cancer	4.27e-05	0.000155	CcSEcCtD
Dinoprost Tromethamine—Hyperhidrosis—Methotrexate—hematologic cancer	4.25e-05	0.000154	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Epirubicin—hematologic cancer	4.24e-05	0.000153	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Triamcinolone—hematologic cancer	4.23e-05	0.000153	CcSEcCtD
Dinoprost Tromethamine—Malaise—Doxorubicin—hematologic cancer	4.2e-05	0.000152	CcSEcCtD
Dinoprost Tromethamine—Rash—Triamcinolone—hematologic cancer	4.19e-05	0.000152	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Triamcinolone—hematologic cancer	4.19e-05	0.000152	CcSEcCtD
Dinoprost Tromethamine—Syncope—Doxorubicin—hematologic cancer	4.18e-05	0.000151	CcSEcCtD
Dinoprost Tromethamine—Headache—Triamcinolone—hematologic cancer	4.17e-05	0.000151	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Prednisone—hematologic cancer	4.15e-05	0.00015	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Prednisone—hematologic cancer	4.15e-05	0.00015	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Dexamethasone—hematologic cancer	4.13e-05	0.000149	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Betamethasone—hematologic cancer	4.13e-05	0.000149	CcSEcCtD
Dinoprost Tromethamine—Hypotension—Methotrexate—hematologic cancer	4.1e-05	0.000149	CcSEcCtD
Dinoprost Tromethamine—Loss of consciousness—Doxorubicin—hematologic cancer	4.09e-05	0.000148	CcSEcCtD
Dinoprost Tromethamine—Infection—Epirubicin—hematologic cancer	4.08e-05	0.000148	CcSEcCtD
Dinoprost Tromethamine—Cough—Doxorubicin—hematologic cancer	4.07e-05	0.000147	CcSEcCtD
Dinoprost Tromethamine—Shock—Epirubicin—hematologic cancer	4.04e-05	0.000146	CcSEcCtD
Dinoprost Tromethamine—Convulsion—Doxorubicin—hematologic cancer	4.04e-05	0.000146	CcSEcCtD
Dinoprost Tromethamine—Hypertension—Doxorubicin—hematologic cancer	4.02e-05	0.000146	CcSEcCtD
Dinoprost Tromethamine—Tachycardia—Epirubicin—hematologic cancer	4.01e-05	0.000145	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Dexamethasone—hematologic cancer	3.99e-05	0.000144	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Betamethasone—hematologic cancer	3.99e-05	0.000144	CcSEcCtD
Dinoprost Tromethamine—Hyperhidrosis—Epirubicin—hematologic cancer	3.97e-05	0.000144	CcSEcCtD
Dinoprost Tromethamine—Chest pain—Doxorubicin—hematologic cancer	3.97e-05	0.000144	CcSEcCtD
Dinoprost Tromethamine—Nausea—Triamcinolone—hematologic cancer	3.95e-05	0.000143	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Methotrexate—hematologic cancer	3.94e-05	0.000143	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Doxorubicin—hematologic cancer	3.92e-05	0.000142	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Methotrexate—hematologic cancer	3.91e-05	0.000142	CcSEcCtD
Dinoprost Tromethamine—Somnolence—Methotrexate—hematologic cancer	3.9e-05	0.000141	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Prednisone—hematologic cancer	3.87e-05	0.00014	CcSEcCtD
Dinoprost Tromethamine—Hypotension—Epirubicin—hematologic cancer	3.84e-05	0.000139	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Dexamethasone—hematologic cancer	3.84e-05	0.000139	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Betamethasone—hematologic cancer	3.84e-05	0.000139	CcSEcCtD
Dinoprost Tromethamine—Rash—Betamethasone—hematologic cancer	3.8e-05	0.000138	CcSEcCtD
Dinoprost Tromethamine—Rash—Dexamethasone—hematologic cancer	3.8e-05	0.000138	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Betamethasone—hematologic cancer	3.8e-05	0.000138	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Dexamethasone—hematologic cancer	3.8e-05	0.000138	CcSEcCtD
Dinoprost Tromethamine—Headache—Dexamethasone—hematologic cancer	3.78e-05	0.000137	CcSEcCtD
Dinoprost Tromethamine—Headache—Betamethasone—hematologic cancer	3.78e-05	0.000137	CcSEcCtD
Dinoprost Tromethamine—Infection—Doxorubicin—hematologic cancer	3.78e-05	0.000137	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Prednisone—hematologic cancer	3.77e-05	0.000136	CcSEcCtD
Dinoprost Tromethamine—Pain—Methotrexate—hematologic cancer	3.76e-05	0.000136	CcSEcCtD
Dinoprost Tromethamine—Shock—Doxorubicin—hematologic cancer	3.74e-05	0.000135	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Prednisone—hematologic cancer	3.72e-05	0.000135	CcSEcCtD
Dinoprost Tromethamine—Tachycardia—Doxorubicin—hematologic cancer	3.71e-05	0.000134	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Epirubicin—hematologic cancer	3.69e-05	0.000134	CcSEcCtD
Dinoprost Tromethamine—Hyperhidrosis—Doxorubicin—hematologic cancer	3.68e-05	0.000133	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Epirubicin—hematologic cancer	3.66e-05	0.000133	CcSEcCtD
Dinoprost Tromethamine—Somnolence—Epirubicin—hematologic cancer	3.65e-05	0.000132	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Methotrexate—hematologic cancer	3.62e-05	0.000131	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Prednisone—hematologic cancer	3.6e-05	0.00013	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Methotrexate—hematologic cancer	3.59e-05	0.00013	CcSEcCtD
Dinoprost Tromethamine—Nausea—Betamethasone—hematologic cancer	3.58e-05	0.00013	CcSEcCtD
Dinoprost Tromethamine—Nausea—Dexamethasone—hematologic cancer	3.58e-05	0.00013	CcSEcCtD
Dinoprost Tromethamine—Hypotension—Doxorubicin—hematologic cancer	3.55e-05	0.000129	CcSEcCtD
Dinoprost Tromethamine—Pain—Epirubicin—hematologic cancer	3.51e-05	0.000127	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Prednisone—hematologic cancer	3.47e-05	0.000126	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Methotrexate—hematologic cancer	3.47e-05	0.000126	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Methotrexate—hematologic cancer	3.47e-05	0.000126	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Doxorubicin—hematologic cancer	3.41e-05	0.000124	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Doxorubicin—hematologic cancer	3.39e-05	0.000123	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Epirubicin—hematologic cancer	3.39e-05	0.000123	CcSEcCtD
Dinoprost Tromethamine—Somnolence—Doxorubicin—hematologic cancer	3.38e-05	0.000122	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Epirubicin—hematologic cancer	3.36e-05	0.000122	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Prednisone—hematologic cancer	3.34e-05	0.000121	CcSEcCtD
Dinoprost Tromethamine—Rash—Prednisone—hematologic cancer	3.31e-05	0.00012	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Prednisone—hematologic cancer	3.31e-05	0.00012	CcSEcCtD
Dinoprost Tromethamine—Headache—Prednisone—hematologic cancer	3.29e-05	0.000119	CcSEcCtD
Dinoprost Tromethamine—Pain—Doxorubicin—hematologic cancer	3.25e-05	0.000118	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Epirubicin—hematologic cancer	3.25e-05	0.000118	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Epirubicin—hematologic cancer	3.25e-05	0.000118	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Methotrexate—hematologic cancer	3.24e-05	0.000117	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Methotrexate—hematologic cancer	3.15e-05	0.000114	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Doxorubicin—hematologic cancer	3.13e-05	0.000113	CcSEcCtD
Dinoprost Tromethamine—Nausea—Prednisone—hematologic cancer	3.12e-05	0.000113	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Doxorubicin—hematologic cancer	3.11e-05	0.000113	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Methotrexate—hematologic cancer	3.11e-05	0.000112	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Epirubicin—hematologic cancer	3.03e-05	0.00011	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Doxorubicin—hematologic cancer	3.01e-05	0.000109	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Doxorubicin—hematologic cancer	3.01e-05	0.000109	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Methotrexate—hematologic cancer	3e-05	0.000109	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Epirubicin—hematologic cancer	2.95e-05	0.000107	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Epirubicin—hematologic cancer	2.91e-05	0.000105	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Methotrexate—hematologic cancer	2.9e-05	0.000105	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Epirubicin—hematologic cancer	2.81e-05	0.000102	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Doxorubicin—hematologic cancer	2.8e-05	0.000101	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Methotrexate—hematologic cancer	2.79e-05	0.000101	CcSEcCtD
Dinoprost Tromethamine—Rash—Methotrexate—hematologic cancer	2.77e-05	0.0001	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Methotrexate—hematologic cancer	2.77e-05	0.0001	CcSEcCtD
Dinoprost Tromethamine—Headache—Methotrexate—hematologic cancer	2.75e-05	9.96e-05	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Doxorubicin—hematologic cancer	2.73e-05	9.88e-05	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Epirubicin—hematologic cancer	2.72e-05	9.84e-05	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Doxorubicin—hematologic cancer	2.69e-05	9.74e-05	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Epirubicin—hematologic cancer	2.61e-05	9.46e-05	CcSEcCtD
Dinoprost Tromethamine—Nausea—Methotrexate—hematologic cancer	2.61e-05	9.44e-05	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Doxorubicin—hematologic cancer	2.6e-05	9.42e-05	CcSEcCtD
Dinoprost Tromethamine—Rash—Epirubicin—hematologic cancer	2.59e-05	9.38e-05	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Epirubicin—hematologic cancer	2.59e-05	9.37e-05	CcSEcCtD
Dinoprost Tromethamine—Headache—Epirubicin—hematologic cancer	2.57e-05	9.32e-05	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Doxorubicin—hematologic cancer	2.51e-05	9.1e-05	CcSEcCtD
Dinoprost Tromethamine—Nausea—Epirubicin—hematologic cancer	2.44e-05	8.84e-05	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Doxorubicin—hematologic cancer	2.42e-05	8.75e-05	CcSEcCtD
Dinoprost Tromethamine—Rash—Doxorubicin—hematologic cancer	2.4e-05	8.68e-05	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Doxorubicin—hematologic cancer	2.4e-05	8.67e-05	CcSEcCtD
Dinoprost Tromethamine—Headache—Doxorubicin—hematologic cancer	2.38e-05	8.62e-05	CcSEcCtD
Dinoprost Tromethamine—Nausea—Doxorubicin—hematologic cancer	2.26e-05	8.18e-05	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—CDKN1B—hematologic cancer	8.35e-06	4.29e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—FGFR3—hematologic cancer	8.35e-06	4.29e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—ESR1—hematologic cancer	8.29e-06	4.26e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—PIK3CA—hematologic cancer	8.29e-06	4.26e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—MAPK14—hematologic cancer	8.27e-06	4.25e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—MAPK14—hematologic cancer	8.27e-06	4.25e-05	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—GPCR downstream signaling—AKT1—hematologic cancer	8.26e-06	4.24e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—MDM2—hematologic cancer	8.25e-06	4.24e-05	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—MYC—hematologic cancer	8.24e-06	4.23e-05	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—TGFB1—hematologic cancer	8.22e-06	4.22e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—SDC1—hematologic cancer	8.2e-06	4.21e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—FN1—hematologic cancer	8.19e-06	4.2e-05	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—CASP3—hematologic cancer	8.19e-06	4.2e-05	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—IL2—hematologic cancer	8.17e-06	4.2e-05	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—IL6—hematologic cancer	8.13e-06	4.18e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—ESR1—hematologic cancer	8.11e-06	4.17e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—ESR1—hematologic cancer	8.11e-06	4.17e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—BAD—hematologic cancer	8.09e-06	4.15e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—NFKBIA—hematologic cancer	8.09e-06	4.15e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—MTOR—hematologic cancer	8.03e-06	4.12e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—PIK3CB—hematologic cancer	8.03e-06	4.12e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—FN1—hematologic cancer	8.01e-06	4.12e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—FN1—hematologic cancer	8.01e-06	4.12e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—NOTCH1—hematologic cancer	8.01e-06	4.11e-05	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—CCND1—hematologic cancer	7.97e-06	4.09e-05	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—JUN—hematologic cancer	7.95e-06	4.08e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—NFKBIA—hematologic cancer	7.92e-06	4.07e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—BAD—hematologic cancer	7.92e-06	4.07e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—BAD—hematologic cancer	7.92e-06	4.07e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—NFKBIA—hematologic cancer	7.92e-06	4.07e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Transmembrane transport of small molecules—CREBBP—hematologic cancer	7.85e-06	4.03e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—CD80—hematologic cancer	7.85e-06	4.03e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—NOTCH1—hematologic cancer	7.84e-06	4.03e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—NOTCH1—hematologic cancer	7.84e-06	4.03e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—KIT—hematologic cancer	7.83e-06	4.02e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—PIK3CG—hematologic cancer	7.83e-06	4.02e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—NRAS—hematologic cancer	7.83e-06	4.02e-05	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—CDKN1A—hematologic cancer	7.71e-06	3.96e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—PTPN11—hematologic cancer	7.7e-06	3.95e-05	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—PTEN—hematologic cancer	7.69e-06	3.95e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—CD80—hematologic cancer	7.68e-06	3.95e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—CD80—hematologic cancer	7.68e-06	3.95e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—KIT—hematologic cancer	7.67e-06	3.94e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—KIT—hematologic cancer	7.67e-06	3.94e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—PIK3CG—hematologic cancer	7.67e-06	3.94e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—PIK3CG—hematologic cancer	7.67e-06	3.94e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—NRAS—hematologic cancer	7.67e-06	3.94e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—NRAS—hematologic cancer	7.67e-06	3.94e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—HRAS—hematologic cancer	7.67e-06	3.94e-05	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—KRAS—hematologic cancer	7.62e-06	3.91e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—PTPN11—hematologic cancer	7.53e-06	3.87e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—PTPN11—hematologic cancer	7.53e-06	3.87e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—CDKN1B—hematologic cancer	7.53e-06	3.87e-05	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—MAPK8—hematologic cancer	7.52e-06	3.86e-05	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—AKT1—hematologic cancer	7.5e-06	3.85e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—MAPK3—hematologic cancer	7.5e-06	3.85e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—CREB1—hematologic cancer	7.46e-06	3.83e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCR downstream signaling—AKT1—hematologic cancer	7.45e-06	3.83e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—CASP3—hematologic cancer	7.38e-06	3.79e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—IL2—hematologic cancer	7.37e-06	3.79e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—BRAF—hematologic cancer	7.36e-06	3.78e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Transmembrane transport of small molecules—ALB—hematologic cancer	7.35e-06	3.78e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—MAPK3—hematologic cancer	7.34e-06	3.77e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—MAPK3—hematologic cancer	7.34e-06	3.77e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—IL6—hematologic cancer	7.34e-06	3.77e-05	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—EP300—hematologic cancer	7.33e-06	3.77e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—CREB1—hematologic cancer	7.3e-06	3.75e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—CREB1—hematologic cancer	7.3e-06	3.75e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—CCL2—hematologic cancer	7.3e-06	3.75e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—IL6R—hematologic cancer	7.28e-06	3.74e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—CREBBP—hematologic cancer	7.26e-06	3.73e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—BRAF—hematologic cancer	7.21e-06	3.7e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—BRAF—hematologic cancer	7.21e-06	3.7e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—CCND1—hematologic cancer	7.19e-06	3.69e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—JUN—hematologic cancer	7.17e-06	3.68e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—CCL2—hematologic cancer	7.14e-06	3.67e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—CCL2—hematologic cancer	7.14e-06	3.67e-05	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—SRC—hematologic cancer	7.13e-06	3.66e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—IL6R—hematologic cancer	7.12e-06	3.66e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—IL6R—hematologic cancer	7.12e-06	3.66e-05	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—PIK3CA—hematologic cancer	7.12e-06	3.65e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—CREBBP—hematologic cancer	7.11e-06	3.65e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—CREBBP—hematologic cancer	7.11e-06	3.65e-05	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—PIK3CA—hematologic cancer	7e-06	3.59e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—CD44—hematologic cancer	6.97e-06	3.58e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—NQO1—hematologic cancer	6.97e-06	3.58e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—CDKN1A—hematologic cancer	6.95e-06	3.57e-05	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—VEGFA—hematologic cancer	6.95e-06	3.57e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—PTEN—hematologic cancer	6.94e-06	3.56e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—MAP2K1—hematologic cancer	6.93e-06	3.56e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—PIK3CD—hematologic cancer	6.89e-06	3.54e-05	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—STAT3—hematologic cancer	6.88e-06	3.53e-05	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—NRAS—hematologic cancer	6.86e-06	3.52e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR downstream signaling—PIK3CA—hematologic cancer	6.82e-06	3.5e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Neuronal System—HRAS—hematologic cancer	6.81e-06	3.5e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—MAPK8—hematologic cancer	6.79e-06	3.49e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—MAP2K1—hematologic cancer	6.79e-06	3.49e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—MAP2K1—hematologic cancer	6.79e-06	3.49e-05	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—TP53—hematologic cancer	6.77e-06	3.48e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—AKT1—hematologic cancer	6.77e-06	3.48e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—KRAS—hematologic cancer	6.74e-06	3.46e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—PIK3CD—hematologic cancer	6.74e-06	3.46e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—PIK3CD—hematologic cancer	6.74e-06	3.46e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR downstream signaling—PIK3CA—hematologic cancer	6.68e-06	3.43e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR downstream signaling—PIK3CA—hematologic cancer	6.68e-06	3.43e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—EP300—hematologic cancer	6.62e-06	3.4e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—KRAS—hematologic cancer	6.6e-06	3.39e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—KRAS—hematologic cancer	6.6e-06	3.39e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—CYCS—hematologic cancer	6.6e-06	3.39e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—FGF2—hematologic cancer	6.59e-06	3.39e-05	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—MAPK3—hematologic cancer	6.57e-06	3.38e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—HSP90AA1—hematologic cancer	6.55e-06	3.37e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—PIK3R1—hematologic cancer	6.5e-06	3.34e-05	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—HRAS—hematologic cancer	6.47e-06	3.33e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—FGF2—hematologic cancer	6.46e-06	3.32e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—FGF2—hematologic cancer	6.46e-06	3.32e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—SRC—hematologic cancer	6.43e-06	3.3e-05	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—MYC—hematologic cancer	6.39e-06	3.28e-05	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—TGFB1—hematologic cancer	6.38e-06	3.27e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—PIK3R1—hematologic cancer	6.37e-06	3.27e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—PIK3R1—hematologic cancer	6.37e-06	3.27e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—JAK2—hematologic cancer	6.32e-06	3.25e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—VEGFA—hematologic cancer	6.27e-06	3.22e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—STAT3—hematologic cancer	6.2e-06	3.19e-05	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—IL6—hematologic cancer	6.2e-06	3.18e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—PIK3CA—hematologic cancer	6.2e-06	3.18e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—NRAS—hematologic cancer	6.19e-06	3.18e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—JAK2—hematologic cancer	6.19e-06	3.18e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—JAK2—hematologic cancer	6.19e-06	3.18e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—MDM2—hematologic cancer	6.17e-06	3.17e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—PIK3CA—hematologic cancer	6.06e-06	3.11e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—PIK3CA—hematologic cancer	6.06e-06	3.11e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—MDM2—hematologic cancer	6.04e-06	3.1e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—MDM2—hematologic cancer	6.04e-06	3.1e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—MTOR—hematologic cancer	6e-06	3.08e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—PIK3CB—hematologic cancer	6e-06	3.08e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—MAPK3—hematologic cancer	5.93e-06	3.04e-05	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—KRAS—hematologic cancer	5.91e-06	3.03e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—MTOR—hematologic cancer	5.88e-06	3.02e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—PIK3CB—hematologic cancer	5.88e-06	3.02e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—MTOR—hematologic cancer	5.88e-06	3.02e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—PIK3CB—hematologic cancer	5.88e-06	3.02e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—GSTP1—hematologic cancer	5.81e-06	2.99e-05	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—AKT1—hematologic cancer	5.81e-06	2.99e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—MYC—hematologic cancer	5.77e-06	2.96e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—TGFB1—hematologic cancer	5.75e-06	2.95e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—HRAS—hematologic cancer	5.73e-06	2.94e-05	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—AKT1—hematologic cancer	5.72e-06	2.94e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—CDKN1B—hematologic cancer	5.63e-06	2.89e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—HRAS—hematologic cancer	5.61e-06	2.88e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—HRAS—hematologic cancer	5.61e-06	2.88e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR downstream signaling—AKT1—hematologic cancer	5.57e-06	2.86e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—CASP3—hematologic cancer	5.52e-06	2.84e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—CDKN1B—hematologic cancer	5.51e-06	2.83e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—CDKN1B—hematologic cancer	5.51e-06	2.83e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—IL2—hematologic cancer	5.51e-06	2.83e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—ABCB1—hematologic cancer	5.5e-06	2.83e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—IL6—hematologic cancer	5.49e-06	2.82e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR downstream signaling—AKT1—hematologic cancer	5.46e-06	2.8e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR downstream signaling—AKT1—hematologic cancer	5.46e-06	2.8e-05	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—PIK3CA—hematologic cancer	5.43e-06	2.79e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—CASP3—hematologic cancer	5.4e-06	2.78e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—CASP3—hematologic cancer	5.4e-06	2.78e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—IL2—hematologic cancer	5.4e-06	2.77e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—IL2—hematologic cancer	5.4e-06	2.77e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—CCND1—hematologic cancer	5.37e-06	2.76e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—IL6—hematologic cancer	5.37e-06	2.76e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—IL6—hematologic cancer	5.37e-06	2.76e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—JUN—hematologic cancer	5.36e-06	2.75e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—GSTM1—hematologic cancer	5.34e-06	2.74e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—NCOR1—hematologic cancer	5.34e-06	2.74e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—KRAS—hematologic cancer	5.33e-06	2.74e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—CCND1—hematologic cancer	5.26e-06	2.7e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—CCND1—hematologic cancer	5.26e-06	2.7e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—JUN—hematologic cancer	5.25e-06	2.7e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—JUN—hematologic cancer	5.25e-06	2.7e-05	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—TP53—hematologic cancer	5.25e-06	2.7e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—CDKN1A—hematologic cancer	5.2e-06	2.67e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—PTEN—hematologic cancer	5.19e-06	2.66e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—CDKN1A—hematologic cancer	5.09e-06	2.61e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—CDKN1A—hematologic cancer	5.09e-06	2.61e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—PTEN—hematologic cancer	5.08e-06	2.61e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—PTEN—hematologic cancer	5.08e-06	2.61e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—MAPK8—hematologic cancer	5.07e-06	2.61e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—AKT1—hematologic cancer	5.06e-06	2.6e-05	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—HRAS—hematologic cancer	5.02e-06	2.58e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—MAPK8—hematologic cancer	4.97e-06	2.55e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—MAPK8—hematologic cancer	4.97e-06	2.55e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—AKT1—hematologic cancer	4.95e-06	2.54e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—AKT1—hematologic cancer	4.95e-06	2.54e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—EP300—hematologic cancer	4.95e-06	2.54e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—PIK3CA—hematologic cancer	4.89e-06	2.51e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—EP300—hematologic cancer	4.84e-06	2.49e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—EP300—hematologic cancer	4.84e-06	2.49e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—SRC—hematologic cancer	4.81e-06	2.47e-05	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—IL6—hematologic cancer	4.8e-06	2.47e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—TP53—hematologic cancer	4.73e-06	2.43e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—MTHFR—hematologic cancer	4.72e-06	2.43e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—SRC—hematologic cancer	4.71e-06	2.42e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—SRC—hematologic cancer	4.71e-06	2.42e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—VEGFA—hematologic cancer	4.69e-06	2.41e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—STAT3—hematologic cancer	4.64e-06	2.38e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—NRAS—hematologic cancer	4.63e-06	2.38e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—VEGFA—hematologic cancer	4.59e-06	2.36e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—VEGFA—hematologic cancer	4.59e-06	2.36e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—STAT3—hematologic cancer	4.54e-06	2.33e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—STAT3—hematologic cancer	4.54e-06	2.33e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—NRAS—hematologic cancer	4.53e-06	2.33e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—NRAS—hematologic cancer	4.53e-06	2.33e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—HRAS—hematologic cancer	4.53e-06	2.33e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—MAPK3—hematologic cancer	4.43e-06	2.28e-05	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—AKT1—hematologic cancer	4.43e-06	2.28e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—MAPK3—hematologic cancer	4.34e-06	2.23e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—MAPK3—hematologic cancer	4.34e-06	2.23e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—IL6—hematologic cancer	4.33e-06	2.23e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—MYC—hematologic cancer	4.31e-06	2.21e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—TGFB1—hematologic cancer	4.3e-06	2.21e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—MYC—hematologic cancer	4.22e-06	2.17e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—MYC—hematologic cancer	4.22e-06	2.17e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—TGFB1—hematologic cancer	4.21e-06	2.16e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—TGFB1—hematologic cancer	4.21e-06	2.16e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—AKT1—hematologic cancer	4e-06	2.05e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—KRAS—hematologic cancer	3.98e-06	2.05e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—PIK3CG—hematologic cancer	3.97e-06	2.04e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—KRAS—hematologic cancer	3.9e-06	2e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—KRAS—hematologic cancer	3.9e-06	2e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—CREBBP—hematologic cancer	3.68e-06	1.89e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—PIK3CA—hematologic cancer	3.66e-06	1.88e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—PIK3CA—hematologic cancer	3.58e-06	1.84e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—PIK3CA—hematologic cancer	3.58e-06	1.84e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—TP53—hematologic cancer	3.54e-06	1.82e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—PIK3CD—hematologic cancer	3.49e-06	1.79e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—TP53—hematologic cancer	3.47e-06	1.78e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—TP53—hematologic cancer	3.47e-06	1.78e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—ALB—hematologic cancer	3.44e-06	1.77e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—HRAS—hematologic cancer	3.39e-06	1.74e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—HRAS—hematologic cancer	3.31e-06	1.7e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—HRAS—hematologic cancer	3.31e-06	1.7e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—PIK3R1—hematologic cancer	3.29e-06	1.69e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—IL6—hematologic cancer	3.24e-06	1.66e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—IL6—hematologic cancer	3.17e-06	1.63e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—IL6—hematologic cancer	3.17e-06	1.63e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—PIK3CB—hematologic cancer	3.04e-06	1.56e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—AKT1—hematologic cancer	2.99e-06	1.54e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—AKT1—hematologic cancer	2.93e-06	1.5e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—AKT1—hematologic cancer	2.93e-06	1.5e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—PTEN—hematologic cancer	2.63e-06	1.35e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—EP300—hematologic cancer	2.51e-06	1.29e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—PIK3CA—hematologic cancer	1.85e-06	9.52e-06	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—AKT1—hematologic cancer	1.51e-06	7.78e-06	CbGpPWpGaD
